|
| |
BioPortfolio's Approved Drugs DatabaseNorvascAmlodipine BesylateDownload PDF containing detailed information.
Press Releases About Norvasc:
|
 |
| AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure |
13th May, 2009 |
Daiichi Sankyo, Inc. |
Fixed-dose combination offers a convenient option that may help patients reduce steps to reach their blood pressure goals while decreasing patient pill burden(1)
PARSIPPANY, N.J., May 13 /PRNewswire/
|
| New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure |
8th May, 2009 |
Daiichi Sankyo, Inc. |
AZTEC Trial First to Examine AZOR Using 24-Hour Ambulatory BP Measures
PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that data presented at the American Society of
|
| Biotech Tracker News - Xolair BLA Re-Submitted |
1st August, 2001 |
Biotracker |
Biotech Tracker News - Xolair BLA Re-Submitted
December 19,
|
| Biotech Tracker News - ALLHAT Studies will Impact Use of Non-Thiazides
|
1st March, 2000 |
Biotracker |
Biotech Tracker News -
ALLHAT Studies will Impact Use of Non-Thiazides More than Use
|
| Sankyo's angiotensin II receptor blocker (ARB) olmesartan medoxomil
|
1st January, 1970 |
Dailyupdates |
Sankyo's
angiotensin II receptor blocker (ARB) olmesartan medoxomil demonstrates
antiinflammatory activity in hypertensive patients.
Earlier
this year data was reported that Sankyo's
|
This page has been viewed 23 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Norvasc across BioPortfolio, or for Norvasc Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|